Cargando…
A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss
BACKGROUND: As schizophrenia patients are typically suspicious of, or are hostile to changes they may be reluctant to accept generic substitution, possibly affecting compliance. This may counteract drug costs savings due to less symptom control and increased hospitalization risk. Although compliance...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652458/ https://www.ncbi.nlm.nih.gov/pubmed/19226465 http://dx.doi.org/10.1186/1472-6963-9-32 |